The CEP290 Gene Meckel Syndrome Type 4 Genetic Test is a specialized diagnostic procedure offered at DNA Labs UAE, designed to identify mutations in the CEP290 gene, which are linked to Meckel Syndrome Type 4. Meckel Syndrome is a rare genetic disorder characterized by kidney cysts, liver fibrosis, and brain anomalies, leading to a range of developmental issues. The CEP290 gene plays a crucial role in cellular structures that are essential for cell division and the development of many body organs.
This test is particularly valuable for families with a history of Meckel Syndrome or for individuals showing symptoms related to the disorder, as it can provide a definitive diagnosis. Early detection through genetic testing can aid in managing symptoms and improving the quality of life for those affected.
The cost of the CEP290 Gene Meckel Syndrome Type 4 Genetic Test at DNA Labs UAE is 4400 AED. This investment covers the detailed analysis required to detect any mutations in the CEP290 gene, providing essential information for diagnosis, treatment planning, and genetic counseling. Given the complexity and the specialized nature of this test, it is conducted with high precision and care, ensuring accurate and reliable results for patients and their families.
The TCTN2 gene plays a crucial role in the proper development of various structures in the body, and mutations in this gene have been linked to Meckel Syndrome Type 8, a rare genetic disorder. This condition is characterized by a combination of symptoms including cystic kidneys, liver fibrosis, and brain anomalies. Early and accurate diagnosis is crucial for managing the syndrome effectively.
DNA Labs UAE offers a specialized genetic test targeting the TCTN2 gene to identify mutations associated with Meckel Syndrome Type 8. The test is designed to provide conclusive results for families seeking answers about this condition. The cost of the test is 4400 AED, reflecting the comprehensive analysis and detailed report provided by the lab.
This genetic test is an essential tool for families with a history of Meckel Syndrome or related symptoms, offering them a chance for early intervention and planning. DNA Labs UAE ensures confidentiality and provides counseling to help understand the results and the implications for the patient and their family.
The B9D1 Gene Meckel Syndrome Type 9 Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify mutations in the B9D1 gene, which are associated with Meckel Syndrome Type 9. Meckel Syndrome is a rare genetic disorder characterized by kidney cysts, liver fibrosis, and malformations in the central nervous system, among other symptoms. The test plays a crucial role in early detection and management of the condition, enabling healthcare providers to tailor interventions and support for affected individuals and their families. The cost of the test is set at 4400 AED, reflecting the comprehensive nature of the analysis and the sophisticated technology employed. By opting for this test at DNA Labs UAE, patients and their families can gain valuable insights into their genetic health, guiding important healthcare decisions.
The UMOD Gene Medullary Cystic Kidney Disease Type 2 Genetic Test is a specialized diagnostic procedure designed to identify mutations in the UMOD gene, which are linked to the development of Medullary Cystic Kidney Disease Type 2 (MCKD2). This condition is a rare form of kidney disease that leads to the formation of cysts in the medulla of the kidneys, eventually causing a gradual decline in kidney function. The test is crucial for individuals with a family history of the disease or those exhibiting symptoms, as early detection can significantly influence management and treatment options.
Performed at DNA Labs UAE, a leading facility in genetic testing, the test offers a comprehensive analysis of the UMOD gene to detect any genetic abnormalities that may predispose an individual to MCKD2. The cost of the test is 4400 AED, reflecting the sophisticated technology and expertise required to accurately identify mutations in the gene. By opting for this test at DNA Labs UAE, patients and their families can gain valuable insights into their genetic makeup, enabling informed decisions about their health and future.
The "PTH Gene Hypoparathyroidism Genetic Test" is a sophisticated diagnostic procedure aimed at identifying mutations in the parathyroid hormone (PTH) gene, which can lead to hypoparathyroidism. Hypoparathyroidism is a rare condition characterized by insufficient production of the PTH hormone, crucial for regulating calcium levels in the blood. This condition can result in a variety of symptoms, including muscle cramps, seizures, and cardiac issues, due to the imbalance of calcium.
The test is particularly valuable for individuals exhibiting symptoms of hypoparathyroidism or those with a family history of the condition, providing a definitive diagnosis and facilitating targeted treatment strategies. Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, the test ensures high accuracy and reliability.
The cost of the PTH Gene Hypoparathyroidism Genetic Test at DNA Labs UAE is 4400 AED. While the price may seem significant, the test's potential to provide a clear genetic insight into a patient's condition makes it a valuable tool in managing and understanding hypoparathyroidism. Early diagnosis and intervention can significantly improve quality of life and reduce the risk of complications associated with the disorder.
The GCM2 gene, also known as glial cells missing homolog 2, plays a crucial role in the development and function of the parathyroid glands, which are essential for regulating calcium levels in the body. Mutations in the GCM2 gene can lead to hypoparathyroidism, a condition characterized by insufficient production of parathyroid hormone (PTH), resulting in low calcium levels in the blood. Familial isolated hypoparathyroidism is a form of the condition that is inherited in a genetic manner, specifically affecting families through generations.
To diagnose this genetic form of hypoparathyroidism, a specialized genetic test is available. This test involves analyzing the patient's DNA to identify mutations in the GCM2 gene that are known to cause the condition. It's a critical tool for confirming the diagnosis, understanding the genetic basis of the disorder, and facilitating appropriate management and treatment strategies for affected individuals and their families.
In the UAE, this specific genetic test for familial isolated hypoparathyroidism caused by GCM2 gene mutations is offered by DNA Labs UAE. The cost of the test is 4400 AED. Conducting the test in a specialized facility like DNA Labs UAE ensures accuracy and reliability of the results, which are essential for the effective management of the condition. This test is particularly valuable for families with a history of hypoparathyroidism, as it can help in identifying at-risk family members and in making informed decisions regarding their health and management of the condition.
The GATA3 Gene Hypoparathyroidism Sensorineural Deafness and Renal Dysplasia Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE. This test is designed to identify mutations in the GATA3 gene, which are known to cause a rare genetic disorder characterized by a constellation of symptoms including hypoparathyroidism, sensorineural deafness, and renal dysplasia. Hypoparathyroidism leads to low levels of calcium in the blood due to inadequate parathyroid hormone production. Sensorineural deafness involves hearing loss that stems from problems in the inner ear or nerve pathways to the brain. Renal dysplasia refers to a malformation of the kidneys that occurs during fetal development.
The test is crucial for early diagnosis and management of the disorder, allowing for appropriate medical interventions to manage symptoms and improve quality of life. Conducted through a blood sample, the test analyzes the GATA3 gene for specific mutations. The cost of the test is 4400 AED, reflecting the specialized nature of the genetic analysis and the expertise required to interpret the results. DNA Labs UAE is equipped with advanced genetic testing technology and staffed by professionals with expertise in genetic disorders, ensuring high-quality diagnostic services.
The TBCE Gene Hypoparathyroidism-Retardation-Dysmorphism (HRD) Syndrome Genetic Test is a specialized diagnostic tool designed to detect mutations in the TBCE gene, which are responsible for the rare genetic disorder known as HRD syndrome. This condition is characterized by a combination of hypoparathyroidism, developmental delays, and distinctive facial and skeletal dysmorphisms. The test plays a crucial role in confirming the diagnosis, enabling early intervention and management of the syndrome.
Performed at DNA Labs UAE, a leading facility in genetic diagnostics, the test involves collecting a DNA sample, typically through a blood draw, from the individual suspected of having HRD syndrome. The laboratory then analyzes the TBCE gene for specific mutations that are indicative of the condition.
The cost of the TBCE Gene Hypoparathyroidism-Retardation-Dysmorphism Syndrome Genetic Test at DNA Labs UAE is set at 4400 AED. This price reflects the comprehensive nature of the test, including the sophisticated technology and expertise required to accurately identify the genetic mutations associated with HRD syndrome. Patients and healthcare providers considering this test can expect a high level of accuracy and reliability from DNA Labs UAE, contributing to better-informed decisions regarding treatment and management of the syndrome.
The "CLCN5 Gene Hypophosphatemic Rickets Genetic Test" is a specialized diagnostic procedure aimed at identifying mutations in the CLCN5 gene, which are linked to a rare form of rickets known as X-linked hypophosphatemic rickets. This condition primarily affects the bones, leading to abnormalities such as bowing of the legs, bone pain, and weakness due to low phosphate levels in the blood. The test is crucial for accurate diagnosis, enabling targeted treatment and management of the condition.
Performed at DNA Labs UAE, a leading facility in genetic diagnostics, the test involves collecting a DNA sample, usually through a blood draw or cheek swab, to analyze the specific gene of interest. DNA Labs UAE employs advanced genetic sequencing technologies to ensure high accuracy and reliability of the test results.
The cost of the "CLCN5 Gene Hypophosphatemic Rickets Genetic Test" at DNA Labs UAE is set at 4400 AED. This price reflects the sophisticated nature of the testing and the specialized expertise required to interpret the results. By opting for this test, patients and their families can gain valuable insights into the genetic basis of the condition, which is instrumental in guiding treatment decisions and managing the disorder effectively.
The "TSHR Gene Hypothyroidism Congenital Nongoitrous Type 1 Genetic Test" is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the TSHR gene, which are responsible for Congenital Nongoitrous Hypothyroidism Type 1. This condition is a form of thyroid dysgenesis where the thyroid gland is present but functions improperly or not at all, leading to decreased levels of thyroid hormone from birth. It is a critical test for early detection and management of this condition, which, if untreated, can lead to growth failure, intellectual disability, and other health issues.
The test involves collecting a DNA sample, usually through a blood draw, and analyzing the TSHR gene for specific mutations. The TSHR (Thyroid Stimulating Hormone Receptor) gene plays a pivotal role in the regulation of thyroid gland development and function. Mutations in this gene can lead to impaired thyroid hormone production, necessitating lifelong thyroid hormone replacement therapy for affected individuals.
DNA Labs UAE offers this test for a cost of 4400 AED. The price reflects the comprehensive analysis and the specialized technology required to accurately identify mutations in the TSHR gene. For families with a history of thyroid disorders or newborns showing symptoms suggestive of hypothyroidism, this test provides essential information for early intervention and treatment planning, aiming to mitigate the potential impacts of the condition on growth and development.
